PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
49.06
ESG score below 80% of RVPH's 63.02. Jim Chanos would check for potential ESG-related litigation and regulatory risks.
63.54
Environmental score 90-95% of RVPH's 70.36. Bill Ackman would demand clear environmental improvement catalysts.
31.02
Social score below 80% of RVPH's 54.02. Jim Chanos would check for potential social license and litigation risks.
52.63
Governance score 80-90% of RVPH's 64.69. Walter Schloss would scrutinize management accountability and board independence.